NDC Pharmacologic Class N0000193802 Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0310-1730Fasenra BenralizumabInjection, SolutionSubcutaneousAstrazeneca Pharmaceuticals LpHuman Prescription Drug

There are 1 NDC products with the pharmacologic class Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA].